This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBZAM（Z6A）株式概要BZAM Ltd.は、ブランド消費財を中心とした大麻生産者として事業を展開している。 詳細Z6A ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析過去1年間で株主の希薄化は大幅に進んだ 意味のある時価総額がありません ( €4M )株式の流動性は非常に低い 最新の財務報告は6か月以上前のものである すべてのリスクチェックを見るZ6A Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW502,015 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG502,015 investors already sharing narrativesYour Fair Value€Current Price€0.01599.6% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-301m709m2016201920222025202620282031Revenue CA$708.9mEarnings CA$104.3mAdvancedSet Fair ValueView all narrativesBZAM Ltd. 競合他社BiofronteraSymbol: XTRA:B8FKMarket cap: €14.6mMPH Health CareSymbol: DB:93M1Market cap: €124.2mSynBioticSymbol: DUSE:SBXMarket cap: €8.4mRedx PharmaSymbol: DB:0RXMarket cap: €65.0m価格と性能株価の高値、安値、推移の概要BZAM過去の株価現在の株価CA$0.01552週高値CA$0.1452週安値CA$0.005ベータ2.691ヶ月の変化0%3ヶ月変化22.95%1年変化-86.36%3年間の変化-99.28%5年間の変化-99.94%IPOからの変化-99.94%最新ニュースお知らせ • Sep 13BZAM to be Delisted from The Canadian Securities ExchangeThe securities of BZAM Ltd. will be delisted from the CSE (Canadian Securities Exchange) at market close on September 11, 2024. BZAM Ltd. is currently suspended.New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €3.69m (US$3.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Market cap is less than US$10m (€3.69m market cap, or US$3.99m).お知らせ • Jan 25+ 1 more updateBZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024BZAM Ltd. announced that Sean Bovingdon, Chief Financial Officer, will be leaving his position on April 30, 2024 to pursue other opportunities. He will remain in his role to ensure a smooth transition, including through the announcement of the Company's results for the fiscal year ending December 31, 2023. The Corporation has commenced a formal search process for a new Chief Financial Officer.お知らせ • Jan 09+ 1 more updateBZAM Ltd. Announces Management ChangesBZAM Ltd. announced that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction"). The Transaction combines BZAM's cultivation, production, and sales infrastructure with the portfolio of international brands that Final Bell is bringing to market in Canada. As part of the Transaction, Greg Boone has joined BZAM as President and Jennifer Maccarone has joined as VP of Operations, while Christy Zhou assumes the role of Chief Legal Officer at BZAM. Matt Milich will remain as Chief Executive Officer of BZAM. In addition, FBHI appointed a nominee, being Kay Jessel, to the board of directors of BZAM (the "Board"), joining existing BZAM board members Bassam Alghanim, who continues as Chair of the Board, Chris Schnarr, Sherry Tross, Keith Merker, Wendy Kaufman, and Sean Bovingdon. Kay Jessel is an experienced economist, asset manager and investment banker, with a track-record of successful capital markets transactions and strategic advisory services for corporations, creditors, and equity owners. Mr. Jessel has held director positions in public and private companies in North America and Europe, including Fila Golf Inc., HeartForce Medical Inc. and Biokronix Inc. Mr. Jessel also co-founded Melchior Kapital AG, a prominent Swiss-German portfolio asset management company specializing in venture capital. His experience has been leveraged by companies worldwide to raise approximately a quarter of a billion dollars in financing. At FBHI, he serves as Executive Director, generally overseeing operations, securityholder communications/investor relations, and fund-raising. Mr. Jessel holds a Diplom-Kaufmann degree from Hamburg University, which is equivalent to an MBA.お知らせ • Dec 06BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. approximately CAD 13.5 million.BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. for approximately CAD 13.5 million on December 5, 2023. Under the terms of the Agreement FBHI will receive 90 million common shares of BZAM at a deemed price of CAD 0.15 per share, representing approximately one-third of the issued and outstanding shares of BZAM. BZAM will also enter into a supply agreement under which FBHI’s wholly owned subsidiary,14th Round Inc., will continue to provide industry leading child-resistant packaging, high-tech vaporization hardware, and pre-roll cones to BZAM. As part of the Transaction, Greg Boone will join BZAM as President and Jennifer Maccarone will join as VP of Operations. FBC’s Chief Legal Officer Christy Zhou will assume the same role at BZAM, and Lana MacKenzie will also take on a senior role within BZAM. Matt Milich will remain as CEO of BZAM. In addition, FBHI will be entitled to appoint a new member to BZAM’s board of directors. Further to the Transaction, the combined Company will be the Canadian home of some of the most recognizable international brands in the cannabis industry. In accordance with the terms of the Agreement, FBHI will enter into a contractual lock-up agreement, whereby the BZAM Shares received at Closing shall be subject to a lock-up, with 1/3 of being released on the 4-month, 8-month, and 12-month anniversaries of the date such shares are issued. As part of the Transaction, FBC will retain a promissory note issued to FBHI in the amount of $4 million, bearing zero percent interest, maturing March 31, 2025, and subordinate to BZAM's current credit facility. Clarus Securities Inc. acted as a exclusive financial advisor to BZAM. Transaction is subject to customary closing conditions and is anticipated to close on or about December 18, 2023.Reported Earnings • Nov 29Third quarter 2023 earnings released: CA$0.084 loss per share (vs CA$0.091 loss in 3Q 2022)Third quarter 2023 results: CA$0.084 loss per share. Revenue: CA$21.0m (up 112% from 3Q 2022). Net loss: CA$15.7m (loss widened 128% from 3Q 2022).最新情報をもっと見るRecent updatesお知らせ • Sep 13BZAM to be Delisted from The Canadian Securities ExchangeThe securities of BZAM Ltd. will be delisted from the CSE (Canadian Securities Exchange) at market close on September 11, 2024. BZAM Ltd. is currently suspended.New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €3.69m (US$3.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Market cap is less than US$10m (€3.69m market cap, or US$3.99m).お知らせ • Jan 25+ 1 more updateBZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024BZAM Ltd. announced that Sean Bovingdon, Chief Financial Officer, will be leaving his position on April 30, 2024 to pursue other opportunities. He will remain in his role to ensure a smooth transition, including through the announcement of the Company's results for the fiscal year ending December 31, 2023. The Corporation has commenced a formal search process for a new Chief Financial Officer.お知らせ • Jan 09+ 1 more updateBZAM Ltd. Announces Management ChangesBZAM Ltd. announced that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction"). The Transaction combines BZAM's cultivation, production, and sales infrastructure with the portfolio of international brands that Final Bell is bringing to market in Canada. As part of the Transaction, Greg Boone has joined BZAM as President and Jennifer Maccarone has joined as VP of Operations, while Christy Zhou assumes the role of Chief Legal Officer at BZAM. Matt Milich will remain as Chief Executive Officer of BZAM. In addition, FBHI appointed a nominee, being Kay Jessel, to the board of directors of BZAM (the "Board"), joining existing BZAM board members Bassam Alghanim, who continues as Chair of the Board, Chris Schnarr, Sherry Tross, Keith Merker, Wendy Kaufman, and Sean Bovingdon. Kay Jessel is an experienced economist, asset manager and investment banker, with a track-record of successful capital markets transactions and strategic advisory services for corporations, creditors, and equity owners. Mr. Jessel has held director positions in public and private companies in North America and Europe, including Fila Golf Inc., HeartForce Medical Inc. and Biokronix Inc. Mr. Jessel also co-founded Melchior Kapital AG, a prominent Swiss-German portfolio asset management company specializing in venture capital. His experience has been leveraged by companies worldwide to raise approximately a quarter of a billion dollars in financing. At FBHI, he serves as Executive Director, generally overseeing operations, securityholder communications/investor relations, and fund-raising. Mr. Jessel holds a Diplom-Kaufmann degree from Hamburg University, which is equivalent to an MBA.お知らせ • Dec 06BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. approximately CAD 13.5 million.BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. for approximately CAD 13.5 million on December 5, 2023. Under the terms of the Agreement FBHI will receive 90 million common shares of BZAM at a deemed price of CAD 0.15 per share, representing approximately one-third of the issued and outstanding shares of BZAM. BZAM will also enter into a supply agreement under which FBHI’s wholly owned subsidiary,14th Round Inc., will continue to provide industry leading child-resistant packaging, high-tech vaporization hardware, and pre-roll cones to BZAM. As part of the Transaction, Greg Boone will join BZAM as President and Jennifer Maccarone will join as VP of Operations. FBC’s Chief Legal Officer Christy Zhou will assume the same role at BZAM, and Lana MacKenzie will also take on a senior role within BZAM. Matt Milich will remain as CEO of BZAM. In addition, FBHI will be entitled to appoint a new member to BZAM’s board of directors. Further to the Transaction, the combined Company will be the Canadian home of some of the most recognizable international brands in the cannabis industry. In accordance with the terms of the Agreement, FBHI will enter into a contractual lock-up agreement, whereby the BZAM Shares received at Closing shall be subject to a lock-up, with 1/3 of being released on the 4-month, 8-month, and 12-month anniversaries of the date such shares are issued. As part of the Transaction, FBC will retain a promissory note issued to FBHI in the amount of $4 million, bearing zero percent interest, maturing March 31, 2025, and subordinate to BZAM's current credit facility. Clarus Securities Inc. acted as a exclusive financial advisor to BZAM. Transaction is subject to customary closing conditions and is anticipated to close on or about December 18, 2023.Reported Earnings • Nov 29Third quarter 2023 earnings released: CA$0.084 loss per share (vs CA$0.091 loss in 3Q 2022)Third quarter 2023 results: CA$0.084 loss per share. Revenue: CA$21.0m (up 112% from 3Q 2022). Net loss: CA$15.7m (loss widened 128% from 3Q 2022).お知らせ • Oct 31BZAM Ltd. announced that it expects to receive CAD 3 million in fundingBZAM Ltd. announced a private placement to issue a loan secured promissory notes from the Chairman and largest shareholder of the Company of up to CAD 3 million on October 30, 2023. The Loan will bear interest at a rate of prime plus 8% per annum and mature no earlier than April 1, 2025. On the same date, the company announced that it has issued 1.19 million in first tranche.お知らせ • Oct 05BZAM Ltd. announced that it expects to receive CAD 2 million in fundingBZAM Ltd. announced that it has entered into an engagement letter with Clarus Securities Inc in best efforts basis and. to issue 15,384,615 units at an issue price of CAD 0.13 per unit for the gross proceeds of CAD 1,999,999.95 led by chairman on October 3, 2023. Each Unit will consist of one common share and one Share purchase warrant with each Warrant entitling the holder thereof to acquire one Share at an exercise price of CAD 0.18 per Warrant Share for a period of three years from the Closing Date. the Agent may offer up to a maximum of 21,153,846 Units for aggregate gross proceeds of approximately CAD 2,750,000 and the Company has granted the Agent an option, exercisable in whole or in part, to purchase up to an additional 3,173,076 Units for a period of 30 days from and including the Closing Date to cover over-allotments, if any, and for market stabilization purposes. The Agent shall be under no obligation whatsoever to exercise the Over-Allotment Option in whole or in part. If the Over-Allotment Option is exercised in full, the aggregate gross proceeds of the Offering will be approximately CAD 3,162,500. The Offering is expected to close on or about October 12, 2023, or such other date as may be agreed upon by the Company and the Agent and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange. The transaction may include participation from certain insiders.お知らせ • Sep 21BZAM Ltd. Provides Revenue Guidance for the Third Quarter of 2023BZAM Ltd. provided revenue guidance for the third quarter of 2023. The company anticipated third quarter net revenue of at least $20.3 million, a 5% increase vs. the prior quarter.Board Change • Aug 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Member of the Advisory Board Tim Seymour is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Aug 25+ 1 more updateAn unknown buyer acquired Midway, BC facility of BZAM Ltd.An unknown buyer acquired Midway, BC facility of BZAM Ltd. on August 4, 2023.An unknown buyer completed the acquisition of Midway, BC facility of BZAM Ltd. on August 4, 2023.お知らせ • Aug 19BZAM Ltd. to Report Q2, 2023 Results on Aug 24, 2023BZAM Ltd. announced that they will report Q2, 2023 results Pre-Market on Aug 24, 2023お知らせ • Aug 12BZAM Ltd. (CNSX:BZAM) completed the acquisition of additional 30.52% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.1 million.BZAM Ltd. (CNSX:BZAM) agreed to acquire additional 13.6% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.05 million on July 13, 2023. As part of the consideration, the buyer issued 0.24 million of common shares in exchange of 0.12 million of target's Class A shares. BZAM Ltd. (CNSX:BZAM) completed the acquisition of additional 30.52% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.1 million on August 10, 2023. As consideration for the Share Purchase, the Company: (i) issued an aggregate of 475,000 common shares of the Company (the "Common Shares") to certain BCC shareholders at a price of between CAD 0.18 and CAD 0.23 per Common Share; and (ii) paid an aggregate of CAD 0.015 million to other BCC shareholders who did not receive Common Shares. The closing of the Share Purchase has resulted in the Company owning 88.2% of BCC, which is a 30.5% increase of the Company's existing ownership stake of BCC.お知らせ • Aug 11An unknown buyer completed the acquisition of Maple Ridge Facility of BZAM Ltd.An unknown buyer entered into a conditionally sale to acquire Maple Ridge Facility of BZAM Ltd. for CAD 4 million on April 7, 2023. The consideration of CAD 4 million is payable 25% in May 2023 and 75% to be paid within one year. BZAM Ltd. had held Maple Ridge Facility for sale as at December 31, 2022. The sale has not closed as the conditions are still to be satisfied. As of May 31, 2023, the transaction is expected to be completed within the next 12 months. An unknown buyer completed the acquisition of Maple Ridge Facility of BZAM Ltd. on August 9, 2023. In accordance with two purchase and sale agreements between BZAM Ltd and arms-length parties dated on August 1and 4, 2023, total gross proceeds received from the transaction were CAD 3.228 million with 50% of the total net proceeds from the Transaction, after commission and costs. BZAM Ltd completed the sale of the majority of its assets in both its Midway properties in B.C, including all associated lands, support buildings, related equipment and on-site biomass.お知らせ • Jul 06An unknown third party acquired Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) for CAD 0.56 million.An unknown third party acquired Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) for CAD 0.56 million on July 4, 2023. BZAM sold all of the issued and outstanding shares in the capital of Galaxie to a third party for CAD 556,522 less usual post closing adjustments. An unknown third party completed the acquisition of Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) on July 4, 2023.お知らせ • May 26BZAM Ltd. to Report Q1, 2023 Results on May 30, 2023BZAM Ltd. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 30, 2023お知らせ • May 20BZAM Ltd. announced that it expects to receive CAD 5 million in fundingBZAM Ltd. announced a a non-brokered private placement of up to approximately 22,222,223 units at an issue price of CAD 0.225 per unit for gross proceeds of CAD 5,000,000 on May 19, 2023. Each Unit will consist of one common share and one Share purchase warrant. Each Warrant entitling the holder thereof to acquire one Share at an exercise price of CAD 0.40 per warrant share for a period of three years from the Closing Date. The transaction is subject to regulatory and CSE approvals. The securities issued will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities legislation. The transaction is expected to close on May 31, 2023.お知らせ • May 12The Green Organic Dutchman Ltd. Receives EU GMP Certification ApprovalThe Green Organic Dutchman Ltd. has received EU GMP certification for the Company's facility located in Ancaster, Ontario. This certification permits the Company to export certain medicinal cannabis products to numerous global markets. The certification is valid for a three-year period from inspection, with a renewal date of August 31, 2025. This certification allows BZAM to execute on existing strategic distribution partnerships which have already been established, including partnerships in Germany and the UK. With regard to the UK, the Company anticipates launching multiple strains under The Green Organic Dutchman brand in Fourth Quarter 2023. With Germany's recent moves toward legalising cannabis for recreational use, BZAM is now well positioned to benefit from regulatory changes as they unfold. The Company expects to see a positive impact on revenue from international sales resulting from EU GMP certification by fourth quarter 2023, if not sooner.お知らせ • Jan 26The Green Organic Dutchman Holdings Ltd. Appoints Bassam Alghanim as Chairman of the BoardThe Green Organic Dutchman Holdings Ltd. announced that Mr. Bassam Alghanim has been appointed Chairman of the Board, effective as at January 24, 2023. Mr. Alghanim brings extensive knowledge and experience to this position, having enjoyed a highly rewarding and successful career as an investor, businessman, and banker spanning four decades.お知らせ • Jan 12+ 1 more updateThe Green Organic Dutchman Holdings Ltd. Announces the Addition of Mr. Bassam Alghanim to Its Board of Directors, to Fill the Vacancy Left by the Resignation of Mr. Tony Moschella from the BoardThe Green Organic Dutchman Holdings Ltd. announced the addition of Mr. Bassam Alghanim to its Board of Directors, to fill the vacancy left by the resignation of Mr. Tony Moschella from the Board. Mr. Alghanim has enjoyed a highly rewarding and successful career as an investor, businessman, and banker spanning four decades. In the 1980s and 1990s, Mr. Alghanim managed and expanded Alghanim Industries, a multi-national conglomerate. Later, Mr. Alghanim spearheaded the acquisition of a controlling stake in Gulf Bank, becoming Chairman in 1999. After leading Gulf Bank for over nearly 10 years, during which it experienced profound growth, Mr. Alghanim moved on to hold diplomatic posts. Mr. Alghanim is appointed by the Board to serve until the next Annual General Shareholders Meeting of the Company, at which the shareholders will vote on the constitution of the Board going forward.お知らせ • Jan 05The Green Organic Dutchman Holdings Ltd. Announces Departure of Michel Gagné as Chief Operating Officer, Effective January 31, 2023The Green Organic Dutchman Holdings Ltd. announced the departure of Mr. Michel Gagné from his position as Chief Operating Officer of the Company, effective as at January 31, 2023.Reported Earnings • Aug 12Second quarter 2021 earnings released: CA$0.061 loss per share (vs CA$0.028 loss in 2Q 2020)The company reported a decent second quarter result with improved revenues, although losses increased and control over costs was weaker. Second quarter 2021 results: Revenue: CA$9.52m (up 115% from 2Q 2020). Net loss: CA$32.5m (loss widened 236% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 59% per year, which means it is performing significantly worse than earnings.Breakeven Date Change • Jun 23Forecast to breakeven in 2023The 3 analysts covering Green Organic Dutchman Holdings expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 62% per year to 2022. The company is expected to make a profit of CA$7.61m in 2023. Average annual earnings growth of 76% is required to achieve expected profit on schedule.Recent Insider Transactions • May 27Independent Director recently bought €139k worth of stockOn the 21st of May, Jacques Dessureault bought around 610k shares on-market at roughly €0.23 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €196k more in shares than they have sold in the last 12 months.Reported Earnings • May 14First quarter 2021 earnings released: EPS CA$0.025 (vs CA$0.23 loss in 1Q 2020)First quarter 2021 results: Revenue: CA$7.70m (up 163% from 1Q 2020). Net income: CA$12.5m (up CA$85.7m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 11Full year 2020 earnings released: CA$0.49 loss per share (vs CA$0.71 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: CA$21.5m (up 96% from FY 2019). Net loss: CA$182.5m (loss narrowed 6.5% from FY 2019).Is New 90 Day High Low • Feb 08New 90-day high: €0.32The company is up 85% from its price of €0.17 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 13% over the same period.Is New 90 Day High Low • Jan 14New 90-day high: €0.23The company is up 32% from its price of €0.17 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.Recent Insider Transactions • Dec 21Independent Chairman of the Board recently bought €33k worth of stockOn the 14th of December, Jeffrey Scott bought around 200k shares on-market at roughly €0.16 per share. This was the largest purchase by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.Reported Earnings • Nov 12Third quarter 2020 earnings released: CA$0.20 loss per shareThe company reported a mediocre third quarter result with increased losses and weaker control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: CA$4.88m (up 93% from 3Q 2019). Net loss: CA$76.1m (loss widened 278% from 3Q 2019).Analyst Estimate Surprise Post Earnings • Nov 12Revenue misses expectationsRevenue missed analyst estimates by 29%. Over the next year, revenue is forecast to grow 246%, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany.Is New 90 Day High Low • Sep 23New 90-day low: €0.20The company is down 11% from its price of €0.23 on 25 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.お知らせ • Aug 08The Green Organic Dutchman Holdings Ltd. to Report Q2, 2020 Results on Aug 12, 2020The Green Organic Dutchman Holdings Ltd. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 12, 2020株主還元Z6ADE PharmaceuticalsDE 市場7D0%0.1%2.0%1Y-86.4%47.3%1.2%株主還元を見る業界別リターン: Z6A過去 1 年間で47.3 % の収益を上げたGerman Pharmaceuticals業界を下回りました。リターン対市場: Z6Aは、過去 1 年間で1.2 % のリターンを上げたGerman市場を下回りました。価格変動Is Z6A's price volatile compared to industry and market?Z6A volatilityZ6A Average Weekly Movementn/aPharmaceuticals Industry Average Movement5.8%Market Average Movement5.5%10% most volatile stocks in DE Market12.6%10% least volatile stocks in DE Market2.8%安定した株価: Z6Aの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のZ6Aのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2016n/aMatt Milichbzam.comBZAM Ltd.は、ブランド化された消費財を中心とした大麻生産者として事業を展開している。同社のブランドには、BZAM、TGOD、ness、Highly Dutch Organic、TABLE TOPのほか、Dunn Cannabis、FRESH、Wyldのパートナーブランドがある。同社はブリティッシュコロンビア州、アルバータ州、オンタリオ州、ケベック州で施設を運営し、マニトバ州ウィニペグとサスカチュワン州レジーナで小売店を展開している。以前はThe Green Organic Dutchman Holdings Ltd.として知られていたが、2023年2月にBZAM Ltd.に社名を変更した。同社は2016年に法人化され、カナダのバンクーバーに本社を置いている。もっと見るBZAM Ltd. 基礎のまとめBZAM の収益と売上を時価総額と比較するとどうか。Z6A 基礎統計学時価総額€4.46m収益（TTM）-€69.56m売上高(TTM)€53.82m0.1xP/Sレシオ-0.1xPER（株価収益率Z6A は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計Z6A 損益計算書（TTM）収益CA$81.65m売上原価CA$54.29m売上総利益CA$27.36mその他の費用CA$132.90m収益-CA$105.54m直近の収益報告Sep 30, 2023次回決算日該当なし一株当たり利益（EPS）-0.39グロス・マージン33.51%純利益率-129.25%有利子負債／自己資本比率42.5%Z6A の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/08/05 15:45終値2024/05/08 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BZAM Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Tamy ChenBMO Capital Markets Equity ResearchChristopher CareyBofA Global ResearchDerek DleyCanaccord Genuity4 その他のアナリストを表示
お知らせ • Sep 13BZAM to be Delisted from The Canadian Securities ExchangeThe securities of BZAM Ltd. will be delisted from the CSE (Canadian Securities Exchange) at market close on September 11, 2024. BZAM Ltd. is currently suspended.
New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €3.69m (US$3.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Market cap is less than US$10m (€3.69m market cap, or US$3.99m).
お知らせ • Jan 25+ 1 more updateBZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024BZAM Ltd. announced that Sean Bovingdon, Chief Financial Officer, will be leaving his position on April 30, 2024 to pursue other opportunities. He will remain in his role to ensure a smooth transition, including through the announcement of the Company's results for the fiscal year ending December 31, 2023. The Corporation has commenced a formal search process for a new Chief Financial Officer.
お知らせ • Jan 09+ 1 more updateBZAM Ltd. Announces Management ChangesBZAM Ltd. announced that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction"). The Transaction combines BZAM's cultivation, production, and sales infrastructure with the portfolio of international brands that Final Bell is bringing to market in Canada. As part of the Transaction, Greg Boone has joined BZAM as President and Jennifer Maccarone has joined as VP of Operations, while Christy Zhou assumes the role of Chief Legal Officer at BZAM. Matt Milich will remain as Chief Executive Officer of BZAM. In addition, FBHI appointed a nominee, being Kay Jessel, to the board of directors of BZAM (the "Board"), joining existing BZAM board members Bassam Alghanim, who continues as Chair of the Board, Chris Schnarr, Sherry Tross, Keith Merker, Wendy Kaufman, and Sean Bovingdon. Kay Jessel is an experienced economist, asset manager and investment banker, with a track-record of successful capital markets transactions and strategic advisory services for corporations, creditors, and equity owners. Mr. Jessel has held director positions in public and private companies in North America and Europe, including Fila Golf Inc., HeartForce Medical Inc. and Biokronix Inc. Mr. Jessel also co-founded Melchior Kapital AG, a prominent Swiss-German portfolio asset management company specializing in venture capital. His experience has been leveraged by companies worldwide to raise approximately a quarter of a billion dollars in financing. At FBHI, he serves as Executive Director, generally overseeing operations, securityholder communications/investor relations, and fund-raising. Mr. Jessel holds a Diplom-Kaufmann degree from Hamburg University, which is equivalent to an MBA.
お知らせ • Dec 06BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. approximately CAD 13.5 million.BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. for approximately CAD 13.5 million on December 5, 2023. Under the terms of the Agreement FBHI will receive 90 million common shares of BZAM at a deemed price of CAD 0.15 per share, representing approximately one-third of the issued and outstanding shares of BZAM. BZAM will also enter into a supply agreement under which FBHI’s wholly owned subsidiary,14th Round Inc., will continue to provide industry leading child-resistant packaging, high-tech vaporization hardware, and pre-roll cones to BZAM. As part of the Transaction, Greg Boone will join BZAM as President and Jennifer Maccarone will join as VP of Operations. FBC’s Chief Legal Officer Christy Zhou will assume the same role at BZAM, and Lana MacKenzie will also take on a senior role within BZAM. Matt Milich will remain as CEO of BZAM. In addition, FBHI will be entitled to appoint a new member to BZAM’s board of directors. Further to the Transaction, the combined Company will be the Canadian home of some of the most recognizable international brands in the cannabis industry. In accordance with the terms of the Agreement, FBHI will enter into a contractual lock-up agreement, whereby the BZAM Shares received at Closing shall be subject to a lock-up, with 1/3 of being released on the 4-month, 8-month, and 12-month anniversaries of the date such shares are issued. As part of the Transaction, FBC will retain a promissory note issued to FBHI in the amount of $4 million, bearing zero percent interest, maturing March 31, 2025, and subordinate to BZAM's current credit facility. Clarus Securities Inc. acted as a exclusive financial advisor to BZAM. Transaction is subject to customary closing conditions and is anticipated to close on or about December 18, 2023.
Reported Earnings • Nov 29Third quarter 2023 earnings released: CA$0.084 loss per share (vs CA$0.091 loss in 3Q 2022)Third quarter 2023 results: CA$0.084 loss per share. Revenue: CA$21.0m (up 112% from 3Q 2022). Net loss: CA$15.7m (loss widened 128% from 3Q 2022).
お知らせ • Sep 13BZAM to be Delisted from The Canadian Securities ExchangeThe securities of BZAM Ltd. will be delisted from the CSE (Canadian Securities Exchange) at market close on September 11, 2024. BZAM Ltd. is currently suspended.
New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €3.69m (US$3.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Market cap is less than US$10m (€3.69m market cap, or US$3.99m).
お知らせ • Jan 25+ 1 more updateBZAM Ltd. Announces Resignation of Sean Bovingdon as Chief Financial Officer, Effective April 30, 2024BZAM Ltd. announced that Sean Bovingdon, Chief Financial Officer, will be leaving his position on April 30, 2024 to pursue other opportunities. He will remain in his role to ensure a smooth transition, including through the announcement of the Company's results for the fiscal year ending December 31, 2023. The Corporation has commenced a formal search process for a new Chief Financial Officer.
お知らせ • Jan 09+ 1 more updateBZAM Ltd. Announces Management ChangesBZAM Ltd. announced that, further to the news release dated December 6, 2023, it has completed the acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. ("FBC") from Final Bell Holdings International Ltd. ("FBHI") (the "Transaction"). The Transaction combines BZAM's cultivation, production, and sales infrastructure with the portfolio of international brands that Final Bell is bringing to market in Canada. As part of the Transaction, Greg Boone has joined BZAM as President and Jennifer Maccarone has joined as VP of Operations, while Christy Zhou assumes the role of Chief Legal Officer at BZAM. Matt Milich will remain as Chief Executive Officer of BZAM. In addition, FBHI appointed a nominee, being Kay Jessel, to the board of directors of BZAM (the "Board"), joining existing BZAM board members Bassam Alghanim, who continues as Chair of the Board, Chris Schnarr, Sherry Tross, Keith Merker, Wendy Kaufman, and Sean Bovingdon. Kay Jessel is an experienced economist, asset manager and investment banker, with a track-record of successful capital markets transactions and strategic advisory services for corporations, creditors, and equity owners. Mr. Jessel has held director positions in public and private companies in North America and Europe, including Fila Golf Inc., HeartForce Medical Inc. and Biokronix Inc. Mr. Jessel also co-founded Melchior Kapital AG, a prominent Swiss-German portfolio asset management company specializing in venture capital. His experience has been leveraged by companies worldwide to raise approximately a quarter of a billion dollars in financing. At FBHI, he serves as Executive Director, generally overseeing operations, securityholder communications/investor relations, and fund-raising. Mr. Jessel holds a Diplom-Kaufmann degree from Hamburg University, which is equivalent to an MBA.
お知らせ • Dec 06BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. approximately CAD 13.5 million.BZAM Ltd. (CNSX:BZAM) entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd. for approximately CAD 13.5 million on December 5, 2023. Under the terms of the Agreement FBHI will receive 90 million common shares of BZAM at a deemed price of CAD 0.15 per share, representing approximately one-third of the issued and outstanding shares of BZAM. BZAM will also enter into a supply agreement under which FBHI’s wholly owned subsidiary,14th Round Inc., will continue to provide industry leading child-resistant packaging, high-tech vaporization hardware, and pre-roll cones to BZAM. As part of the Transaction, Greg Boone will join BZAM as President and Jennifer Maccarone will join as VP of Operations. FBC’s Chief Legal Officer Christy Zhou will assume the same role at BZAM, and Lana MacKenzie will also take on a senior role within BZAM. Matt Milich will remain as CEO of BZAM. In addition, FBHI will be entitled to appoint a new member to BZAM’s board of directors. Further to the Transaction, the combined Company will be the Canadian home of some of the most recognizable international brands in the cannabis industry. In accordance with the terms of the Agreement, FBHI will enter into a contractual lock-up agreement, whereby the BZAM Shares received at Closing shall be subject to a lock-up, with 1/3 of being released on the 4-month, 8-month, and 12-month anniversaries of the date such shares are issued. As part of the Transaction, FBC will retain a promissory note issued to FBHI in the amount of $4 million, bearing zero percent interest, maturing March 31, 2025, and subordinate to BZAM's current credit facility. Clarus Securities Inc. acted as a exclusive financial advisor to BZAM. Transaction is subject to customary closing conditions and is anticipated to close on or about December 18, 2023.
Reported Earnings • Nov 29Third quarter 2023 earnings released: CA$0.084 loss per share (vs CA$0.091 loss in 3Q 2022)Third quarter 2023 results: CA$0.084 loss per share. Revenue: CA$21.0m (up 112% from 3Q 2022). Net loss: CA$15.7m (loss widened 128% from 3Q 2022).
お知らせ • Oct 31BZAM Ltd. announced that it expects to receive CAD 3 million in fundingBZAM Ltd. announced a private placement to issue a loan secured promissory notes from the Chairman and largest shareholder of the Company of up to CAD 3 million on October 30, 2023. The Loan will bear interest at a rate of prime plus 8% per annum and mature no earlier than April 1, 2025. On the same date, the company announced that it has issued 1.19 million in first tranche.
お知らせ • Oct 05BZAM Ltd. announced that it expects to receive CAD 2 million in fundingBZAM Ltd. announced that it has entered into an engagement letter with Clarus Securities Inc in best efforts basis and. to issue 15,384,615 units at an issue price of CAD 0.13 per unit for the gross proceeds of CAD 1,999,999.95 led by chairman on October 3, 2023. Each Unit will consist of one common share and one Share purchase warrant with each Warrant entitling the holder thereof to acquire one Share at an exercise price of CAD 0.18 per Warrant Share for a period of three years from the Closing Date. the Agent may offer up to a maximum of 21,153,846 Units for aggregate gross proceeds of approximately CAD 2,750,000 and the Company has granted the Agent an option, exercisable in whole or in part, to purchase up to an additional 3,173,076 Units for a period of 30 days from and including the Closing Date to cover over-allotments, if any, and for market stabilization purposes. The Agent shall be under no obligation whatsoever to exercise the Over-Allotment Option in whole or in part. If the Over-Allotment Option is exercised in full, the aggregate gross proceeds of the Offering will be approximately CAD 3,162,500. The Offering is expected to close on or about October 12, 2023, or such other date as may be agreed upon by the Company and the Agent and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange. The transaction may include participation from certain insiders.
お知らせ • Sep 21BZAM Ltd. Provides Revenue Guidance for the Third Quarter of 2023BZAM Ltd. provided revenue guidance for the third quarter of 2023. The company anticipated third quarter net revenue of at least $20.3 million, a 5% increase vs. the prior quarter.
Board Change • Aug 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Member of the Advisory Board Tim Seymour is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Aug 25+ 1 more updateAn unknown buyer acquired Midway, BC facility of BZAM Ltd.An unknown buyer acquired Midway, BC facility of BZAM Ltd. on August 4, 2023.An unknown buyer completed the acquisition of Midway, BC facility of BZAM Ltd. on August 4, 2023.
お知らせ • Aug 19BZAM Ltd. to Report Q2, 2023 Results on Aug 24, 2023BZAM Ltd. announced that they will report Q2, 2023 results Pre-Market on Aug 24, 2023
お知らせ • Aug 12BZAM Ltd. (CNSX:BZAM) completed the acquisition of additional 30.52% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.1 million.BZAM Ltd. (CNSX:BZAM) agreed to acquire additional 13.6% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.05 million on July 13, 2023. As part of the consideration, the buyer issued 0.24 million of common shares in exchange of 0.12 million of target's Class A shares. BZAM Ltd. (CNSX:BZAM) completed the acquisition of additional 30.52% stake of BZAM Holdings, Inc. from certain minority shareholders for CAD 0.1 million on August 10, 2023. As consideration for the Share Purchase, the Company: (i) issued an aggregate of 475,000 common shares of the Company (the "Common Shares") to certain BCC shareholders at a price of between CAD 0.18 and CAD 0.23 per Common Share; and (ii) paid an aggregate of CAD 0.015 million to other BCC shareholders who did not receive Common Shares. The closing of the Share Purchase has resulted in the Company owning 88.2% of BCC, which is a 30.5% increase of the Company's existing ownership stake of BCC.
お知らせ • Aug 11An unknown buyer completed the acquisition of Maple Ridge Facility of BZAM Ltd.An unknown buyer entered into a conditionally sale to acquire Maple Ridge Facility of BZAM Ltd. for CAD 4 million on April 7, 2023. The consideration of CAD 4 million is payable 25% in May 2023 and 75% to be paid within one year. BZAM Ltd. had held Maple Ridge Facility for sale as at December 31, 2022. The sale has not closed as the conditions are still to be satisfied. As of May 31, 2023, the transaction is expected to be completed within the next 12 months. An unknown buyer completed the acquisition of Maple Ridge Facility of BZAM Ltd. on August 9, 2023. In accordance with two purchase and sale agreements between BZAM Ltd and arms-length parties dated on August 1and 4, 2023, total gross proceeds received from the transaction were CAD 3.228 million with 50% of the total net proceeds from the Transaction, after commission and costs. BZAM Ltd completed the sale of the majority of its assets in both its Midway properties in B.C, including all associated lands, support buildings, related equipment and on-site biomass.
お知らせ • Jul 06An unknown third party acquired Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) for CAD 0.56 million.An unknown third party acquired Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) for CAD 0.56 million on July 4, 2023. BZAM sold all of the issued and outstanding shares in the capital of Galaxie to a third party for CAD 556,522 less usual post closing adjustments. An unknown third party completed the acquisition of Galaxie Brands Corp. from BZAM Ltd. (CNSX:BZAM) on July 4, 2023.
お知らせ • May 26BZAM Ltd. to Report Q1, 2023 Results on May 30, 2023BZAM Ltd. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 30, 2023
お知らせ • May 20BZAM Ltd. announced that it expects to receive CAD 5 million in fundingBZAM Ltd. announced a a non-brokered private placement of up to approximately 22,222,223 units at an issue price of CAD 0.225 per unit for gross proceeds of CAD 5,000,000 on May 19, 2023. Each Unit will consist of one common share and one Share purchase warrant. Each Warrant entitling the holder thereof to acquire one Share at an exercise price of CAD 0.40 per warrant share for a period of three years from the Closing Date. The transaction is subject to regulatory and CSE approvals. The securities issued will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities legislation. The transaction is expected to close on May 31, 2023.
お知らせ • May 12The Green Organic Dutchman Ltd. Receives EU GMP Certification ApprovalThe Green Organic Dutchman Ltd. has received EU GMP certification for the Company's facility located in Ancaster, Ontario. This certification permits the Company to export certain medicinal cannabis products to numerous global markets. The certification is valid for a three-year period from inspection, with a renewal date of August 31, 2025. This certification allows BZAM to execute on existing strategic distribution partnerships which have already been established, including partnerships in Germany and the UK. With regard to the UK, the Company anticipates launching multiple strains under The Green Organic Dutchman brand in Fourth Quarter 2023. With Germany's recent moves toward legalising cannabis for recreational use, BZAM is now well positioned to benefit from regulatory changes as they unfold. The Company expects to see a positive impact on revenue from international sales resulting from EU GMP certification by fourth quarter 2023, if not sooner.
お知らせ • Jan 26The Green Organic Dutchman Holdings Ltd. Appoints Bassam Alghanim as Chairman of the BoardThe Green Organic Dutchman Holdings Ltd. announced that Mr. Bassam Alghanim has been appointed Chairman of the Board, effective as at January 24, 2023. Mr. Alghanim brings extensive knowledge and experience to this position, having enjoyed a highly rewarding and successful career as an investor, businessman, and banker spanning four decades.
お知らせ • Jan 12+ 1 more updateThe Green Organic Dutchman Holdings Ltd. Announces the Addition of Mr. Bassam Alghanim to Its Board of Directors, to Fill the Vacancy Left by the Resignation of Mr. Tony Moschella from the BoardThe Green Organic Dutchman Holdings Ltd. announced the addition of Mr. Bassam Alghanim to its Board of Directors, to fill the vacancy left by the resignation of Mr. Tony Moschella from the Board. Mr. Alghanim has enjoyed a highly rewarding and successful career as an investor, businessman, and banker spanning four decades. In the 1980s and 1990s, Mr. Alghanim managed and expanded Alghanim Industries, a multi-national conglomerate. Later, Mr. Alghanim spearheaded the acquisition of a controlling stake in Gulf Bank, becoming Chairman in 1999. After leading Gulf Bank for over nearly 10 years, during which it experienced profound growth, Mr. Alghanim moved on to hold diplomatic posts. Mr. Alghanim is appointed by the Board to serve until the next Annual General Shareholders Meeting of the Company, at which the shareholders will vote on the constitution of the Board going forward.
お知らせ • Jan 05The Green Organic Dutchman Holdings Ltd. Announces Departure of Michel Gagné as Chief Operating Officer, Effective January 31, 2023The Green Organic Dutchman Holdings Ltd. announced the departure of Mr. Michel Gagné from his position as Chief Operating Officer of the Company, effective as at January 31, 2023.
Reported Earnings • Aug 12Second quarter 2021 earnings released: CA$0.061 loss per share (vs CA$0.028 loss in 2Q 2020)The company reported a decent second quarter result with improved revenues, although losses increased and control over costs was weaker. Second quarter 2021 results: Revenue: CA$9.52m (up 115% from 2Q 2020). Net loss: CA$32.5m (loss widened 236% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 59% per year, which means it is performing significantly worse than earnings.
Breakeven Date Change • Jun 23Forecast to breakeven in 2023The 3 analysts covering Green Organic Dutchman Holdings expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 62% per year to 2022. The company is expected to make a profit of CA$7.61m in 2023. Average annual earnings growth of 76% is required to achieve expected profit on schedule.
Recent Insider Transactions • May 27Independent Director recently bought €139k worth of stockOn the 21st of May, Jacques Dessureault bought around 610k shares on-market at roughly €0.23 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €196k more in shares than they have sold in the last 12 months.
Reported Earnings • May 14First quarter 2021 earnings released: EPS CA$0.025 (vs CA$0.23 loss in 1Q 2020)First quarter 2021 results: Revenue: CA$7.70m (up 163% from 1Q 2020). Net income: CA$12.5m (up CA$85.7m from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 11Full year 2020 earnings released: CA$0.49 loss per share (vs CA$0.71 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: CA$21.5m (up 96% from FY 2019). Net loss: CA$182.5m (loss narrowed 6.5% from FY 2019).
Is New 90 Day High Low • Feb 08New 90-day high: €0.32The company is up 85% from its price of €0.17 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 13% over the same period.
Is New 90 Day High Low • Jan 14New 90-day high: €0.23The company is up 32% from its price of €0.17 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.
Recent Insider Transactions • Dec 21Independent Chairman of the Board recently bought €33k worth of stockOn the 14th of December, Jeffrey Scott bought around 200k shares on-market at roughly €0.16 per share. This was the largest purchase by an insider in the last 3 months. This was Jeffrey's only on-market trade for the last 12 months.
Reported Earnings • Nov 12Third quarter 2020 earnings released: CA$0.20 loss per shareThe company reported a mediocre third quarter result with increased losses and weaker control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: CA$4.88m (up 93% from 3Q 2019). Net loss: CA$76.1m (loss widened 278% from 3Q 2019).
Analyst Estimate Surprise Post Earnings • Nov 12Revenue misses expectationsRevenue missed analyst estimates by 29%. Over the next year, revenue is forecast to grow 246%, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany.
Is New 90 Day High Low • Sep 23New 90-day low: €0.20The company is down 11% from its price of €0.23 on 25 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.
お知らせ • Aug 08The Green Organic Dutchman Holdings Ltd. to Report Q2, 2020 Results on Aug 12, 2020The Green Organic Dutchman Holdings Ltd. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 12, 2020
